A biocompatible membrane comprised of alginate and hyaluronate. The membrane may be used to prevent unwanted scarring after surgery. The tissue adherence and the rate of bioresorption of the membrane may be modified through an external stimulus comprising a sequestering agent and a viscosity modifier.

The present disclosure provides devices and methods for the treatment of ophthalmological conditions such as dry eye. Among the devices provided are punctal plugs and devices for inserting punctal plugs. The punctal plugs may be shaped for insertion in the punctum and/or the canaliculus. They may also be coated with a bioadhesive. Methods for inserting the punctal plugs are provided, as well as methods for preparing bioadhesive-coated punctal plugs. A method is also provided to treat dry-eye using a bioadhesive without use of a punctal plug.

The present disclosure provides devices and methods for the treatment of ophthalmological conditions such as dry eye. Among the devices provided are punctal plugs and devices for inserting punctal plugs. The punctal plugs may be shaped for insertion in the punctum and/or the canaliculus. They may also be coated with a bioadhesive. Methods for inserting the punctal plugs are provided, as well as methods for preparing bioadhesive-coated punctal plugs. A method is also provided to treat dry-eye using a bioadhesive without use of a punctal plug.

A composite material comprising an elastomer and nanocellulose. The nanocellulose may comprise a nanocellulose material derived from plants having C4 leaf anatomy, or a nanocellulose material derived from a plant material having a lesser amount of lignin than hemi-cellulose, or a nanocellulose having a hemicellulose content of from 25% to 55% by weight of the nanocellulose material, or a nanocellulose comprising nanofibrils having a diameter of up to 5 nm, or a nanocellulose comprising nanocellulose material of plant origin comprising nanocellulose particles or fibres having an aspect ratio of at least 250, or the composite material having a stiffness of not greater than 2.5 times the stiffness of the elastomer without the nanocellulose material being present, or the nanocellulose particles or fibres being derived from a plant material having a hemicellulose content of 30% or higher (w/w). The nanocellulose may be derived from arid Spinifex.

The present invention relates to a radical scavenging and anti-yellowing composition for polymeric materials and compositions containing the same. The invention further relates to medical devices comprising a composition according to the invention and to a method of sterilizing such devices.

Meshes for use to control the movement of bodily fluids, such as blood, are described herein. The mesh can be partially or completely biodegradable or non-biodegradable. In one embodiment, the mesh is formed from one or more self-assembling peptides. The peptides can be in the form of fibers, such as nanofibers. The peptides can be assembled prior to formation of the mesh or after the mesh has been formed but before it is applied. Alternatively, the mesh can be prepared from unassembled peptides, which assemble at the time of application. The peptides can assemble upon contact with bodily fluids (e.g., blood) or can be contacted with an ionic solution to initiate assembly.

The present invention relates to an animal model with ischemic heart disease, by a 3-dimensional bioprinted occluder and method for producing the same.

The present invention relates to an animal model with ischemic heart disease, by a 3-dimensional bioprinted occluder and method for producing the same.

Biomaterials and methods and uses for repair or augmentation of tissues are provided. In particular, the invention provides a multi-layered, naturally occurring multi-axial oriented biomaterial comprising predominately type I collagen fibers. The invention further provides methods and uses for repair or augmentation of tissues using biomaterials of the invention.

A first object of the present invention is to provide an antithrombotic cell adhesion sheet having excellent antithrombotic properties and cell adhesion properties. In addition, a second object of the present invention is to provide a medical device with a sheet using the antithrombotic cell adhesion sheet.

The antithrombotic cell adhesion sheet of the present invention is a sheet formed b using a compound represented by General Formula (1).

##STR00001##

In General Formula (1), R.sup.1 and R.sup.4 each independently represent a hydrogen atom or a methyl group. R.sup.2 and R.sup.3 each independently represent —CH.sub.2CH(R.sup.A1)CH.sub.2—. p and r represent 1. q represents 0 or 1. m and n each independently represent an integer of 2 to 6. R.sup.A1 represents a hydrogen atom or a methyl group.